Literature DB >> 3967830

Liver in obesity.

A Braillon, J P Capron, M A Hervé, C Degott, C Quenum.   

Abstract

We report on clinical, nutritional, and hepatic histological findings in 50 non-selected obese subjects (mean overweight +74%; range +21-138%). The pathogenesis of the liver damage was assessed with the help of multidimensional analysis of a number of clinical variables. According to the severity of the hepatic lesions, the patients have been ranged in five groups: O (normal liver) 10%; I (fatty liver) 48%; II (fatty hepatitis) 26%; III (fatty fibrosis) 8%; IV (fatty cirrhosis) 8%. The more severe changes (groups III and IV) were constantly associated with excessive alcohol intake. The multidimensional analysis was unable to find a relationship between obesity and the development of fibrosis and cirrhosis whereas it showed that: (a) there was a highly significant correlation between the daily ethanol intake and the degree of overweight, (b) severe fatty metamorphosis was significantly associated with the degree of overweight, the existence of diabetes mellitus, and the amount of alcohol and fat intake, (c) nutritional factors, in particular deficient protein intake, have only an accessory effect in the development of mild inflammation and fibrosis, (d) the consumption of potentially hepatotoxic drugs, very high in the obese (about five drugs per day) could have a role in the development of cirrhosis. In conclusion in our study, there was no evidence that obesity per se could result in severe liver damage.

Entities:  

Mesh:

Year:  1985        PMID: 3967830      PMCID: PMC1432435          DOI: 10.1136/gut.26.2.133

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Fatty liver: biochemical and clinical considerations.

Authors:  A M Hoyumpa; H L Greene; G D Dunn; S Schenker
Journal:  Am J Dig Dis       Date:  1975-12

2.  Liver impairment in the obese.

Authors:  J O WESTWATER; D FAINER
Journal:  Gastroenterology       Date:  1958-04       Impact factor: 22.682

3.  The liver in obesity.

Authors:  S ZELMAN
Journal:  AMA Arch Intern Med       Date:  1952-08

4.  Fatty metamorphosis of the liver in morbid obesity.

Authors:  W H Kern; A H Heger; J H Payne; L T DeWind
Journal:  Arch Pathol       Date:  1973-11

5.  The liver in morbid obesity and following bypass surgery for obesity.

Authors:  A T Marubbio; R D Rucker; P D Schneider; J P Horstmann; R L Varco; H Buchwald
Journal:  Surg Clin North Am       Date:  1979-12       Impact factor: 2.741

6.  Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case.

Authors:  S Itoh; S Matsuo; A Ichinoe; Y Yamaba; M Miyazawa
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

7.  Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.

Authors:  K R Falchuk; S C Fiske; R C Haggitt; M Federman; C Trey
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

8.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

9.  Hepatic morphology in obesity.

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

10.  Intestinal bacterial metabolism of protein and bile acids: role in pathogenesis of hepatic disease after jejuno-ileal bypass surgery.

Authors:  P R Powell-Jackson; D P Maudgal; D Sharp; A Goldie; J D Maxwell
Journal:  Br J Surg       Date:  1979-11       Impact factor: 6.939

View more
  21 in total

1.  Various S-GOT/S-GPT ratios in nonviral liver disorders and related physical conditions and life-style.

Authors:  Masako Mukai; Kotaro Ozasa; Kyohei Hayashi; Keiichi Kawai
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Nonalcoholic fatty liver disease treated by gastroplasty.

Authors:  K Jaskiewicz; S Raczynska; R Rzepko; Z Sledziński
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Sodium perchlorate induces non-alcoholic fatty liver disease in developing stickleback.

Authors:  Michael R Minicozzi; Frank A von Hippel; Christoff G Furin; C Loren Buck
Journal:  Environ Pollut       Date:  2019-05-02       Impact factor: 8.071

4.  Endoscopic injection of alcohol for bleeding from gastroduodenal vascular anomalies.

Authors:  J D Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-11

5.  Obscure gastrointestinal bleeding.

Authors:  A C Steger; J Spencer
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

6.  The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model.

Authors:  Gabor Bekesi; Zsolt Tulassay; Gabriella Lengyel; Zsuzsa Schaff; Dezso Szombath; Julia Stark; Istvan Marczell; Peter Nagy-Repas; Ildiko Adler; Elek Dinya; Karoly Racz; Kalman Magyar
Journal:  J Neural Transm (Vienna)       Date:  2011-06-05       Impact factor: 3.575

7.  Nonalcoholic fatty liver disease during valproate therapy.

Authors:  Alberto Verrotti; Giovanna Di Marco; Rosanna la Torre; Piernicola Pelliccia; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2009-01-30       Impact factor: 3.183

Review 8.  Clinical pharmacokinetics of drugs in obesity. An update.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

9.  Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.

Authors:  G Donati; B Stagni; F Piscaglia; N Venturoli; A M Morselli-Labate; L Rasciti; L Bolondi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?

Authors:  Harjot K Gill; George Y Wu
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.